NKGN Stock Alert: The Alzheimer’s News That Has NKGen Biotech Soaring Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

NKGen Biotech stock is up with heavy trading of NKGN shares alongside approval for its Phase 2 clinical trial of its Alzheimer’s treatment.

The post NKGN Stock Alert: The Alzheimer’s News That Has NKGen Biotech Soaring Today appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.